Rite Aid Corp.

Camp Hill, Pa. -- Rite Aid Corporation is beefing up its risk management.

The drugstore chain announced that Paul Zikmund, a risk management professional with nearly 30 years of experience, is joining Rite Aid as group VP of risk and controls.

In this new position, Zikmund will oversee the risk management program for Rite Aid as well as its subsidiaries, RediClinic, Health Dialog and EnvisionRx. Zikmund will report to Tony Bellezza, Rite Aid senior VP and chief compliance officer.

Rite Aid has named a 30-year company veteran to the newly created post of group VP of risk and controls.

Rite Aid will be teaming with the Skin Cancer Foundation for the eighth consecutive year to provide Rite Aid customers free private screenings with a local dermatologist volunteer.

Camp Hill, Pa. -- A veteran Target executive is joining Rite Aid.

The drugstore chain on Monday announced that Bryan Everett is joining Rite Aid as executive VP store operations, effective Aug. 3. He will be responsible for all operations at the company’s nearly 4,600 chainwide stores and will report to Rite Aid president and COO Ken Martindale.

A former Target executive who led new format, new store and remodeling programs while also overseeing pharmacies and clinics is joining Rite Aid as executive vice president of store operations.

Bryan Everett will be responsible for all operations at the company’s nearly 4,600 chainwide stores and will report to Rite Aid’s president and COO Ken Martindale. Everett will succeed Bob Thompson, who has announced his retirement from the company, effective January.

Camp Hill, Pa. – Shareholders of Rite Aid Corp. have voted to tighten the reins of the “golden parachute” payment CEO John Standley will receive if the company is acquired and he loses his job as a result. Standley had previously been slated to receive $42 million in such an event, including $31.6 million in vested equity.

CAMP HILL, Pa. — Rite Aid announced on Wednesday that it has completed its previously announced acquisition of Envision Pharmaceutical Services from global private investment firm TPG and other shareholders. The transaction is valued at approximately $2 billion, including approximately $1.8 billion in cash and approximately 27.9 million Rite Aid shares.

Camp Hill, Pa. -- Rite Aid's first-quarter earnings plunged 55%, mainly on costs tied to a $2 billion acquisition. The chain also lowered its full-year profit outlook.

The drugstore chain in February announced that it would buy pharmacy benefits manager EnvisionRx.  Rite Aid said it expects the deal, expected to close by the beginning of July, to increase its annual revenue by as much as 18.6%.

The retailer earned $18.8 million in the quarter that ended May 30, down from $41.4 million in the year ago period.

On the heels of big news from rival drugstore CVS this week, Rite Aid says it is expecting its EnvisionRx acquisition to increase the company's annual revenue by as much as 18.6%.

Same store sales increased 2.1% at Rite Aid in May thanks in large part to growth in the retailer's pharmacy division.